Gregory Y. H. Lip is an internationally recognised British cardiologist and academic leader whose work has had a major influence on the modern management of atrial fibrillation, thrombosis, and stroke prevention. He is based in the United Kingdom and has held senior academic and clinical appointments across Europe and Asia. Throughout his career, he has combined clinical cardiology, population-based research, and guideline development, becoming one of the most cited and influential figures in cardiovascular medicine.
Academic History
Professor Lip undertook his medical education and postgraduate training in the United Kingdom, progressing through specialist training in internal medicine and cardiology before focusing his academic career on cardiovascular medicine, arrhythmias, and thrombosis.
He currently holds the Price-Evans Chair of Cardiovascular Medicine at the University of Liverpool. In addition to his primary appointment, he has developed an extensive international academic portfolio, reflecting the global impact of his research. He is Distinguished Professor at Aalborg University in Denmark and Adjunct Professor at Yonsei University in Seoul, Korea. He also serves as Visiting Professor at Aston University in Birmingham, England, and Visiting Professor of Cardiology at Belgrade University, Serbia.
Career Overview
Professor Lip is Director of the Liverpool Centre for Cardiovascular Science, a major collaboration between the University of Liverpool and Liverpool Heart & Chest Hospital. In this role, he has led multidisciplinary research programmes focused on cardiovascular outcomes, atrial fibrillation, thrombosis, and stroke prevention, integrating clinical care with population health and translational science.
His research has been central to the development and validation of risk stratification tools and evidence-based approaches for atrial fibrillation management, anticoagulation therapy, and prevention of thromboembolic events. His work is widely cited and has shaped international clinical practice and health policy.
Professor Lip has held numerous leadership roles within major professional societies. He is a member of the European Heart Rhythm Association (EHRA) and serves as Chairman of its Scientific Documents Committee, overseeing the development of consensus statements and guidance documents. He also serves on the board of the Working Group on Thrombosis of the European Society of Cardiology.
In addition to his European roles, he has contributed directly to national healthcare policy in the United Kingdom, having served as a clinical adviser for the National Institute for Health and Care Excellence (NICE) guidelines on the management of atrial fibrillation.
Professor Lip is also actively involved in medical publishing. He serves as a Section Editor for Arrhythmia & Electrophysiology Review, contributing to the dissemination of high-quality research and expert reviews in heart rhythm disorders.
Career Timeline
- Medical education and specialist cardiology training in the United Kingdom
- Appointment to senior academic roles in cardiovascular medicine
- Named Price-Evans Chair of Cardiovascular Medicine, University of Liverpool
- Appointed Director, Liverpool Centre for Cardiovascular Science
- Distinguished Professor, Aalborg University, Denmark
- Adjunct Professor, Yonsei University, Seoul, Korea
- Visiting Professor roles in the United Kingdom and Serbia
- Chairman, EHRA Scientific Documents Committee
- Clinical adviser to NICE atrial fibrillation guidelines
- Section Editor, Arrhythmia & Electrophysiology Review
Recognition
Professor Lip is widely recognised as one of the world’s leading authorities on atrial fibrillation, thrombosis, and stroke prevention. His research has informed international guidelines, national health policy, and everyday clinical decision-making. He is a frequent invited speaker at major global cardiology congresses and is consistently ranked among the most highly cited researchers in cardiovascular medicine.
Areas of Speciality
- Atrial Fibrillation
- Stroke Prevention
- Anticoagulation and Thrombosis
- Cardiovascular Risk Stratification
- Population and Outcomes Research
- Evidence-Based Cardiology
Sources
